Morphine Completed Phase 3 Trials for Pain / Sickle Cell Disease (SCD) Treatment

Indications	Status	Purpose	Phase
DBCOND0012160 (Pain) DBCOND0128712 (Sickle Cell Disease (SCD))	Completed	Treatment	3

clinicaltrials.gov Identifier	Title	Drugs
https://clinicaltrials.gov/ct2/show/	Choosing Opioid Management for Pain and Analyzing Acute Chest Syndrome (ACS) Rates Equally	Morphine (DB00295) Nalbuphine (DB00844)